节点文献

度洛西汀治疗抑郁症及广泛性焦虑障碍临床应用指导建议

Clinical therapeutic recommendation on duloxtine in treatment of major depressive disorder and generalized anxiety disorder

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 江开达李凌江王刚司天梅黄继忠许秀峰方贻儒李惠春陆峥梅其一贾福军李涛赵靖平吴文源张明园

【Author】 JIANG Kai-da~1,LI Ling-jiang~2,WANG Gang~3,SI Tian-mei~4,HUANG Ji-zhong~1,XU Xiu-feng~5, FANG Yi-ru~1,LI Hui-chun~6,LU Zheng~7,MEI Qi-yi~8,JIA Fu-jun~9,LI Tao~(10),ZHAO Jing-ping~2, WU Wen-yuan~7,ZHANG Ming-yuan~1 (1.Shanghai Mental Health Center,Shanghai Jiaotong University School of Medicine,SHANGHAI 200030, China;2.Institue of Mental Health,the Second Xiangya Hospital of Centre South Univensity,Changsha HUNAN 410011,China;3.Beijing An Ding Hospital,BEIJING 100088,China;4.Institue of Mental Health, Peking University,BEIJING 100083,China;5.First Hospital of Kunming Medical College,Kunming YUNNAN 650032,China;6.The Second Affiliated Hospital of Zhejiang University School of Medicine,Hangzhou ZHEJIANG 310009,China;7.Tongji University School of Medicine,SHANGHAI 200092,China;8. Suzhou Guangji Hospital,Suzhou JIANGSU 215008,China;9.Guangdong General Hospital,Guangdong Pronvincial Institute of Mental Health,Guangzhou GUANGDONG 510120,China;10.Huaxi Hospital of Sichuan University,Chengdu SICHUAN 610041,China)

【机构】 上海交通大学医学院附属精神卫生中心中南大学湘雅二医院精神卫生研究所北京安定医院北京大学精神卫生研究所昆明医学院第一附属医院浙江大学医学院附属二院上海同济大学医学院苏州市广济医院广东省人民医院广东省精神卫生研究所四川大学华西医院

【摘要】 抑郁症及广泛性焦虑障碍都是常见的负性情绪障碍,具有患病率高、复发率高、致残率高的特点,目前倡导全病程治疗。新型抗抑郁药均能治疗抑郁症及广泛性焦虑障碍,度洛西汀作为5-羟色胺与去甲肾上腺素再摄取抑制剂类抗抑郁药物的一种,有大量临床证据表明,其在抗抑郁、抗焦虑治疗方面具有起效快、临床治愈率高及安全性好、不良反应少等特点。本文重点介绍近年来国内外在度洛西汀临床应用中的治疗学和循证医学研究进展,结合广大专家的用药经验,为临床医生提供更客观、更规范的治疗选择和治疗方案,以进一步改善患者预后,促进患者回归社会。

【Abstract】 Depression and generalized anxiety disorder(GAD),which are considered as common negative mood disorder,are charactered by high rate of prevelance,recurrence,and disability,and should be treated over the course of the whole disease.New antidepressants have high efficiency in the treatment of depression and GAD.Duloxetine,which belongs to the SNRIs,is charactered by fast onset of action,higher cure rate and safety and less adverse reaction.The paper mainly introduced the recent research progress in therapeutics and evidence based medicine of duloxetine in clinical practice,and also provided the more objective and standard treatment projects combined with expert experience,in order to improve the prognosis of patient and promote the patient to return to society.

  • 【文献出处】 中国新药与临床杂志 ,Chinese Journal of New Drugs and Clinical Remedies , 编辑部邮箱 ,2012年09期
  • 【分类号】R749.72
  • 【被引频次】46
  • 【下载频次】1360
节点文献中: 

本文链接的文献网络图示:

本文的引文网络